Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caimiao Wei

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivoWenhong Ren, Borys Korchin, Quan-Sheng Zhu, et al.
American Journal of Clinical Oncology|June 19, 2012
Delayed systemic recurrence of uveal melanomaNathalie A Kolandjian, Caimiao Wei, Sapna P Patel, et al.
Cancer Research|November 18, 2008
PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survivalChandra Bartholomeusz, Daniel Rosen, Caimiao Wei, et al.
Evolution & Development|June 13, 2014
Functional analysis of limb transcriptional enhancers in the mouseMark J Nolte, Ying Wang, Jian Min Deng, et al.
Translational Lung Cancer Research|December 10, 2025
Stage- and smoking-associated microRNA expression in lung adenocarcinomaMin Huang, Yimin Ge, Huiqin Chen, et al.
The Oncologist|September 4, 2023
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or BothMarc P Bonaca, Javid J Moslehi, Jonathan A Ledermann, et al.
Oncotarget|December 30, 2014
A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapyAaron Raymond, Bin Liu, Hong Liang, et al.
Investigational New Drugs|May 8, 2015
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancerZahi Mitri, Cansu Karakas, Caimiao Wei, et al.
Clinical Breast Cancer|October 27, 2012
A prospective study of bone tumor response assessment in metastatic breast cancerNaoki Hayashi, Colleen M Costelloe, Tsuyoshi Hamaoka, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivoWenhong Ren, Borys Korchin, Quan-Sheng Zhu, et al.
American Journal of Clinical Oncology|June 19, 2012
Delayed systemic recurrence of uveal melanomaNathalie A Kolandjian, Caimiao Wei, Sapna P Patel, et al.
Cancer Research|November 18, 2008
PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survivalChandra Bartholomeusz, Daniel Rosen, Caimiao Wei, et al.
Evolution & Development|June 13, 2014
Functional analysis of limb transcriptional enhancers in the mouseMark J Nolte, Ying Wang, Jian Min Deng, et al.
Translational Lung Cancer Research|December 10, 2025
Stage- and smoking-associated microRNA expression in lung adenocarcinomaMin Huang, Yimin Ge, Huiqin Chen, et al.
The Oncologist|September 4, 2023
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or BothMarc P Bonaca, Javid J Moslehi, Jonathan A Ledermann, et al.
Oncotarget|December 30, 2014
A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapyAaron Raymond, Bin Liu, Hong Liang, et al.
Investigational New Drugs|May 8, 2015
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancerZahi Mitri, Cansu Karakas, Caimiao Wei, et al.
Clinical Breast Cancer|October 27, 2012
A prospective study of bone tumor response assessment in metastatic breast cancerNaoki Hayashi, Colleen M Costelloe, Tsuyoshi Hamaoka, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Pageof 7